pSivida Corp Announces First Quarter FY 2016 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
pSivida Corp Announces First Quarter FY 2016 Financial Results Release Date and Conference Call Information

WATERTOWN, Mass., Oct. 30, 2015 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that its financial results for the first quarter of fiscal year 2016 will be released after the market close on Thursday, November 5, 2015, followed the same day by a conference call and live webcast scheduled for 4:30 p.m. ET.

The conference call may be accessed by dialing (877) 312-7507 from the U.S. and Canada, or (631) 813-4828 from international locations. The conference ID is 67983411. A live webcast will be available on the Investor Relations section of the corporate website at http://www.psivida.com .

A replay of the call will be available beginning November 5, 2015, at approximately 7:30 p.m. ET and ending on November 12, 2015, at 11:59 p.m. ET. The replay may be accessed by dialing (855) 859-2056 within the U.S. and Canada or (404) 537-3406 from international locations, Conference ID Number: 67983411. A replay of the webcast will also be available on the corporate website during that time.

About pSivida Corp. pSivida Corp. ( www.psivida.com ), headquartered in Watertown, MA, is a leader in the development of sustained release, drug delivery products for treating eye diseases. pSivida has developed three of only four FDA-approved treatments for back-of-the-eye diseases. The most recent, ILUVIEN®, a micro-insert for diabetic macular edema, licensed to Alimera Sciences, is currently sold in the U.S. and three EU countries. Retisert®, an implant for posterior uveitis, is licensed to and sold by Bausch & Lomb. pSivida’s lead product candidate, Medidur™, a micro-insert for posterior uveitis being independently developed, is currently in pivotal Phase III clinical trials, with an NDA anticipated in the first half of 2017. pSivida’s pre-clinical development program is focused on using its core platform technologies Durasert™ and Tethadur™ to deliver drugs and biologics to treat wet and dry age-related macular degeneration, glaucoma, osteoarthritis and other diseases. To learn more about pSivida please visit www.psivida.com and connect on Twitter , LinkedIn , Facebook and Google+ .

SAFE HARBOR STATEMENTS UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: Various statements made in this release are forward-looking, and are inherently subject to risks, uncertainties and potentially inaccurate assumptions. All statements that address activities, events or developments that we intend, expect or believe may occur in the future are forward-looking statements. Some of the factors that could cause actual results to differ materially from the anticipated results or other expectations expressed, anticipated or implied in our forward-looking statements include uncertainties with respect to: our ability to achieve profitable operations and access to capital; further impairment of our intangible assets; fluctuations in our operating results; declines in Retisert royalties; successful commercialization of, and receipt of revenues from, ILUVIEN for DME; the effect of pricing and reimbursement decisions on sales of ILUVIEN for DME; consequences of flucinolone acetonide side effects; safety and efficacy results of Medidur Phase III trials, timing of filing and acceptance of the Medidur NDA, if at all; ability to use data in a U.S. NDA from trials outside the U.S.; any exercise by Pfizer of its option with respect to the Latanoprost product; our ability to develop Tethadur to successfully deliver large biologic molecules and develop products using it; our ability to successfully develop product candidates, initiate and complete clinical trials and receive regulatory approvals; our ability to market and sell products; the success of current and future license agreements; termination or breach of current license agreements; effects of competition and other developments affecting sales of products; market acceptance of products; effects of guidelines, recommendations and studies; protection of intellectual property and avoiding intellectual property infringement; retention of key personnel; product liability; industry consolidation; compliance with environmental laws; manufacturing risks; risks and costs of international business operations; legislative or regulatory changes; volatility of stock price; possible dilution; absence of dividends; and other factors described in our filings with the SEC. You should read and interpret any forward-looking statements in light of these risks. Should known or unknown risks materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected in the forward-looking statements. You should bear this in mind as you consider any forward-looking statements. Our forward-looking statements speak only as of the dates on which they are made. We do not undertake any obligation to publicly update or revise our forward-looking statements, even if experience or future changes makes it clear that any projected results expressed or implied in such statements will not be realized. 

Martin E. Janis & Company, Inc. Beverly Jedynak President +1 312 943 1123 M: +1 773 350 5793 bjedynak@janispr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 0

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 202

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 49

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
Early Dog Guarding Signs Matter Before a Sudden Growl

Updated Category News Views 24

A bowl, a chewed-up toy, or a patch of couch can turn tense in a heartbeat. That is why the useful part of Brian Manning's guidance is not some fantasy of making every dog endlessly tolerant; it is learning to notice discomfort while there is still room to back off safely. For anybody watching the pet-care and behavior-training field, this is the kind of plainspoken...

Continue Reading
Miami I20 Tests Appetite for Long-Term U.S. Capital

Updated Category News Views 28

Five days in a Miami airport hotel may not sound like the machinery of national investment policy, yet the guest list for the inaugural I20 Summit is serious enough to make capital markets sit up. From December 11 through 15, the Sovereign Wealth Fund Institute plans to bring sovereign funds, pensions, endowments, family offices, business leaders and U.S....

Continue Reading
1095 Days Finds the Army's Long, Ordinary War Life

Updated Category News Views 89

A cracked barracks window can explain more than a polished battlefield legend. Dean R. Cherry's 1095 Days: Three Years in the Green Machine, newly released by Palmetto Publishing, puts its weight on the parts of Army life that war stories often shove into the background: cold, waiting, paperwork, arbitrary rules, lousy living conditions, and the private mental math of...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 83

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
Bank of America AML Claims Put Controls Under Fire

Updated Category News Views 157

A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 42

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
America's Group Adds Swansea to Its UK Auction Map

Updated Category News Views 38

A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...

Continue Reading

Top 5 Most Recently Viewed Articles

Venus Concept Strengthens Financial Position with Debt Exchange

Updated Category News Views 173

Venus Concept Optimizes Capital Structure through Debt Exchange Venus Concept Inc. is making waves in the medical aesthetic technology industry with its recent strategic financial decision. The company, known for its innovative solutions, has successfully exchanged $11 million worth of subordinated convertible notes for 379,311 shares of Series Y preferred stock. This...

Continue Reading
Understanding the Recent Decline of Gentex Corporation Stock

Updated Category News Views 284

Why Is Gentex Corporation Stock Down? Gentex Corporation (NASDAQ:GNTX) shares have recently faced a decline after revealing third-quarter earnings that fell short of expectations. The drop can be largely attributed to lower-than-expected earnings per share (EPS) and sales figures. Quarterly Earnings Performance For the third quarter, Gentex reported adjusted earnings of...

Continue Reading
Elliott Pressures Northern Star: Board Shake-Up Needed

Updated Category News Views 59

Reckoning Time for Northern Star Resources Well, it's about time someone rattled the cage at Northern Star. Elliott Management, never one to sit on its laurels, is clapping back at the board with a stern letter, raising eyebrows and hopes for a shake-up. They're putting their 5.6% stake to work, backing their talk with a lineup of heavyweight board candidates. The message...

Continue Reading
CBD's Role in Supporting World Cup Soccer Players

Updated Category News Views 60

World Cup Sparks Focus on Player Recovery An event like the FIFA World Cup doesn't just put its spotlight on dazzling goals and nail-biting penalty shootouts; it throws the grueling demands placed on players into sharp relief. With fixtures spread across sprawling global schedules, these athletes barely get time to breathe between matches. Rest Rules Let Players Recharge...

Continue Reading
Middlefield Canadian Income PCC: Major Holdings Announcement

Updated Category News Views 185

Overview of Middlefield Canadian Income PCC Holdings Middlefield Canadian Income PCC is actively engaged in managing major holdings and ensuring transparency in its share structure. The company recently issued a comprehensive notification, detailing the current shareholding status and changes in voting rights, importantly reflecting the interests of its shareholders....

Continue Reading